In-person AND virtual! – We pioneered a new conference format that connected in-person and virtual audiences to create a unique experience. Matching the innovation that comes through our members’ work, ISPOR pushed the boundaries of innovation to design an event that worked in today’s quickly changing environment.

While the live portion of ISPOR Europe 2022 is now over, you may still register for the virtual only portion. Gain access to nearly all in-person and virtual content available on-demand as well as ISPOR’s robust virtual platform which includes networking and posters.

On-demand session recordings as well as virtual posters and networking will be available through 9 December 2022. 

 

Download the program guide

Development, Evaluation and Adoption of Digital Health Technologies: How Stakeholders Need to Interact to Make This Work?

Speaker(s)

Moderator: Pilar Pinilla, MSc, NICE International, National Institute for Health and Care Excellence, London, UK
Panelists: Rosa Maria Vivanco-Hidalgo, MD, PhD, MPH, HTA Unit, Agency for Health Quality and Assessment of Catalonia, Barcelona, Spain; Mark Salmon, BSc, MBA, NICE International, National Institute for Health and Care Excellence, Manchester, UK; Felip Miralles, PhD, Digital Health Unit, Technology Centre of Catalonia (Eurecat), Barcelona, Spain

ISSUE: The digital health context is chaotic and vast, with innovation progressing at pace and healthcare systems increasingly demanding digital solutions to contribute to patients benefits and optimise resources. This complex environment requires a whole system approach. This panel will showcase the experiences from 2 HTA agencies in developing tools to support the development, evaluation and adoption of digital health technologies in their jurisdictions. These will be contrasted with the perspective from the developer on how these tools can accelerate adoption of digital health technologies. How do stakeholders need to interact to make this works?

OVERVIEW:

Pilar will provide an overview of the digital health landscape and the identification of stakeholders that are likely to be involved in the development, evaluation and adoption of digital health technologies. The session will be interactive, with questions posed to the audience on relevant stakeholders and their needs from each other. Anyone interested in the evaluation and adoption of digital healthcare technologies should attend.

Farhan will present how NICE (UK) is aiming to establish its role in the evaluation of the value of digital health technologies, providing best practice guidance on evidence and evaluation methods for digital health technologies and collaborating with system partners. Rosa will share the experience from AQuAS (Spain), as the HTA agency developing a framework for evaluating digital health technologies nationally and regionally. Both will share how interactions with system partners have been crucial.

Felip will provide an overview of paradigmatic developments of digital health from the perspective of Eurecat’s digital health unit, which promotes transformation of health with support from innovative digital technologies. Highlights regarding how evidence standards frameworks can be useful to developers to accelerate adoption of digital health solutions in clinical practice will be discussed.

There will be Q&A and the audience will be invited to present their views.

Code

302

Topic

Medical Technologies